Bromfenac 0.09% Versus Dexamethasone 0.1% Ophthalmic Solutions to Reduce Inflammation After Cataract Surgery
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 26 Jun 2018
At a glance
- Drugs Bromfenac (Primary) ; Dexamethasone
- Indications Ocular inflammation
- Focus Therapeutic Use
- 15 Jun 2018 Planned End Date changed from 1 Oct 2018 to 1 Dec 2018.
- 15 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 27 Oct 2017 New trial record